nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Influenza like illness—Tiotropium—chronic obstructive pulmonary disease	0.0221	0.0229	CcSEcCtD
Terconazole—Dysmenorrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0191	0.0198	CcSEcCtD
Terconazole—Itraconazole—CYP1A1—chronic obstructive pulmonary disease	0.017	0.459	CrCbGaD
Terconazole—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0147	0.0152	CcSEcCtD
Terconazole—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.0143	0.0148	CcSEcCtD
Terconazole—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0135	0.014	CcSEcCtD
Terconazole—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0133	0.0138	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0118	0.0122	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.0117	0.0122	CcSEcCtD
Terconazole—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.0113	0.0118	CcSEcCtD
Terconazole—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.0113	0.0118	CcSEcCtD
Terconazole—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.0107	0.0111	CcSEcCtD
Terconazole—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.011	CcSEcCtD
Terconazole—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.0105	0.011	CcSEcCtD
Terconazole—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0102	0.0106	CcSEcCtD
Terconazole—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.0102	0.0106	CcSEcCtD
Terconazole—Ketoconazole—CYP1A1—chronic obstructive pulmonary disease	0.0102	0.275	CrCbGaD
Terconazole—Ketoconazole—CYP1A2—chronic obstructive pulmonary disease	0.00983	0.265	CrCbGaD
Terconazole—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0095	0.00987	CcSEcCtD
Terconazole—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00925	0.00961	CcSEcCtD
Terconazole—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0086	0.00893	CcSEcCtD
Terconazole—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00853	0.00886	CcSEcCtD
Terconazole—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00846	0.00879	CcSEcCtD
Terconazole—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00846	0.00879	CcSEcCtD
Terconazole—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0082	0.00852	CcSEcCtD
Terconazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00813	0.00844	CcSEcCtD
Terconazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00812	0.00844	CcSEcCtD
Terconazole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00808	0.00839	CcSEcCtD
Terconazole—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00781	0.00811	CcSEcCtD
Terconazole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00766	0.00796	CcSEcCtD
Terconazole—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00744	0.00773	CcSEcCtD
Terconazole—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00744	0.00773	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00739	0.00767	CcSEcCtD
Terconazole—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00723	0.00751	CcSEcCtD
Terconazole—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00723	0.00751	CcSEcCtD
Terconazole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00703	0.0073	CcSEcCtD
Terconazole—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00703	0.0073	CcSEcCtD
Terconazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00683	0.0071	CcSEcCtD
Terconazole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00683	0.00709	CcSEcCtD
Terconazole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00683	0.00709	CcSEcCtD
Terconazole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00683	0.00709	CcSEcCtD
Terconazole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00683	0.00709	CcSEcCtD
Terconazole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00683	0.00709	CcSEcCtD
Terconazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0068	0.00706	CcSEcCtD
Terconazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0068	0.00706	CcSEcCtD
Terconazole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00675	0.00701	CcSEcCtD
Terconazole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00675	0.00701	CcSEcCtD
Terconazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00669	0.00695	CcSEcCtD
Terconazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00669	0.00695	CcSEcCtD
Terconazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00663	0.00689	CcSEcCtD
Terconazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00655	0.0068	CcSEcCtD
Terconazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00655	0.0068	CcSEcCtD
Terconazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00645	0.0067	CcSEcCtD
Terconazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00645	0.0067	CcSEcCtD
Terconazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00644	0.00669	CcSEcCtD
Terconazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00641	0.00666	CcSEcCtD
Terconazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00641	0.00666	CcSEcCtD
Terconazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00637	0.00662	CcSEcCtD
Terconazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00634	0.00658	CcSEcCtD
Terconazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00618	0.00642	CcSEcCtD
Terconazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00608	0.00632	CcSEcCtD
Terconazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00598	0.00621	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00596	0.00619	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00596	0.00619	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00584	0.00607	CcSEcCtD
Terconazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00574	0.00596	CcSEcCtD
Terconazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00569	0.00591	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00563	0.00585	CcSEcCtD
Terconazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.0056	0.00581	CcSEcCtD
Terconazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0056	0.00581	CcSEcCtD
Terconazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.00548	0.00569	CcSEcCtD
Terconazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00547	0.00568	CcSEcCtD
Terconazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00542	0.00563	CcSEcCtD
Terconazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00542	0.00563	CcSEcCtD
Terconazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00539	0.0056	CcSEcCtD
Terconazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00539	0.0056	CcSEcCtD
Terconazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00539	0.0056	CcSEcCtD
Terconazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00536	0.00557	CcSEcCtD
Terconazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00535	0.00556	CcSEcCtD
Terconazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00535	0.00556	CcSEcCtD
Terconazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00529	0.00549	CcSEcCtD
Terconazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00524	0.00544	CcSEcCtD
Terconazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.0052	0.0054	CcSEcCtD
Terconazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.0052	0.0054	CcSEcCtD
Terconazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00517	0.00537	CcSEcCtD
Terconazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00517	0.00537	CcSEcCtD
Terconazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00517	0.00537	CcSEcCtD
Terconazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00517	0.00537	CcSEcCtD
Terconazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00516	0.00536	CcSEcCtD
Terconazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00511	0.00531	CcSEcCtD
Terconazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00511	0.00531	CcSEcCtD
Terconazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00511	0.00531	CcSEcCtD
Terconazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00509	0.00529	CcSEcCtD
Terconazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00509	0.00529	CcSEcCtD
Terconazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00508	0.00528	CcSEcCtD
Terconazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00507	0.00526	CcSEcCtD
Terconazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00507	0.00526	CcSEcCtD
Terconazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00506	0.00525	CcSEcCtD
Terconazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00505	0.00525	CcSEcCtD
Terconazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00491	0.0051	CcSEcCtD
Terconazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00489	0.00507	CcSEcCtD
Terconazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00489	0.00507	CcSEcCtD
Terconazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00482	0.00501	CcSEcCtD
Terconazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00482	0.00501	CcSEcCtD
Terconazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00482	0.005	CcSEcCtD
Terconazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00472	0.00491	CcSEcCtD
Terconazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0047	0.00488	CcSEcCtD
Terconazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0047	0.00488	CcSEcCtD
Terconazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00463	0.00481	CcSEcCtD
Terconazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00463	0.00481	CcSEcCtD
Terconazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0046	0.00478	CcSEcCtD
Terconazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00455	0.00473	CcSEcCtD
Terconazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00454	0.00471	CcSEcCtD
Terconazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00443	0.00461	CcSEcCtD
Terconazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00437	0.00454	CcSEcCtD
Terconazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00433	0.0045	CcSEcCtD
Terconazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00433	0.0045	CcSEcCtD
Terconazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00424	0.0044	CcSEcCtD
Terconazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00416	0.00432	CcSEcCtD
Terconazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00416	0.00432	CcSEcCtD
Terconazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00413	0.00429	CcSEcCtD
Terconazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.00413	0.00429	CcSEcCtD
Terconazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00412	0.00428	CcSEcCtD
Terconazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00412	0.00428	CcSEcCtD
Terconazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0041	0.00426	CcSEcCtD
Terconazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.0041	0.00426	CcSEcCtD
Terconazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00409	0.00424	CcSEcCtD
Terconazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00408	0.00423	CcSEcCtD
Terconazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.00404	0.0042	CcSEcCtD
Terconazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00404	0.00419	CcSEcCtD
Terconazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00403	0.00419	CcSEcCtD
Terconazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.00402	0.00417	CcSEcCtD
Terconazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00393	0.00408	CcSEcCtD
Terconazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.00407	CcSEcCtD
Terconazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0039	0.00405	CcSEcCtD
Terconazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.00404	CcSEcCtD
Terconazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00389	0.00404	CcSEcCtD
Terconazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00389	0.00404	CcSEcCtD
Terconazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00387	0.00402	CcSEcCtD
Terconazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00381	0.00395	CcSEcCtD
Terconazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00381	CcSEcCtD
Terconazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00365	0.00379	CcSEcCtD
Terconazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00355	0.00368	CcSEcCtD
Terconazole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00303	0.00315	CcSEcCtD
Terconazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00293	0.00304	CcSEcCtD
Terconazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00292	0.00303	CcSEcCtD
Terconazole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00285	0.00296	CcSEcCtD
Terconazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.00292	CcSEcCtD
Terconazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00269	0.00279	CcSEcCtD
Terconazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00269	0.00279	CcSEcCtD
Terconazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00266	0.00276	CcSEcCtD
Terconazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00261	0.00271	CcSEcCtD
Terconazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00258	0.00268	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00235	0.00244	CcSEcCtD
Terconazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00234	0.00243	CcSEcCtD
Terconazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.00232	CcSEcCtD
Terconazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00223	0.00232	CcSEcCtD
Terconazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00222	0.00231	CcSEcCtD
Terconazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00212	0.0022	CcSEcCtD
Terconazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00211	0.00219	CcSEcCtD
Terconazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00211	0.00219	CcSEcCtD
Terconazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00213	CcSEcCtD
Terconazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00204	0.00211	CcSEcCtD
Terconazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00204	0.00211	CcSEcCtD
Terconazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0019	0.00197	CcSEcCtD
Terconazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00185	0.00192	CcSEcCtD
Terconazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00182	0.00189	CcSEcCtD
Terconazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0017	0.00177	CcSEcCtD
Terconazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00164	0.0017	CcSEcCtD
Terconazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00169	CcSEcCtD
Terconazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00169	CcSEcCtD
Terconazole—Headache—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00168	CcSEcCtD
Terconazole—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00159	CcSEcCtD
